# PROFIL Study to Investigate the Effect of GPB on NfL Levels in Patients With Corticobasal Syndrome (CBS)

> **NCT05983588** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Technical University of Munich** · enrollment: 32 (estimated)

## Conditions studied

- Corticobasal Syndrome (CBS)

## Interventions

- **DRUG:** RAVICTI 1.1 g/ml
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05983588
- **Lead sponsor:** Technical University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-12-12
- **Primary completion:** 2026-03-30
- **Final completion:** 2026-03-30
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05983588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05983588, "PROFIL Study to Investigate the Effect of GPB on NfL Levels in Patients With Corticobasal Syndrome (CBS)". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05983588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*